| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 680936 | Null | 0.0174563696971638 | 0.3480626 |
| NSC 682306 | N-[p-[N-(2,4,7-triamino-6-pteriddinylmethyl)-N-methylamino]benzoyl]glutamic acid | 0.0174563696971638 | 0.26827152 |
| NSC 689534 | Hydrazinecarbothioamide, N,N-bis[(2-pyridinyl)methyl]-2-[(2-pyridinyl)methylene]- | 0.0174563696971638 | 0.12629047 |
| NSC 690558 | Null | 0.0174563696971638 | 0.38066755 |
| NSC 692738 | Null | 0.0174563696971638 | 0.12623132 |
| NSC 724827 | 1,4-di-N-oxide-6,7-difluoro-2-ethylcarbonyl-3-trifluoromethy lquinoxaline | 0.0174563696971638 | 0.3787813 |
| NSC 726444 | 4,11-bis[[2-(methylamino)ethyl]amino]-3-[(dimethylamino)meth yl]-1H-naphtho[2,3-f]indole-5,10-dione | 0.0174563696971638 | 0.32471217 |
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.0174563696971638 | 0.47290616 |
| NSC 728319 | 6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride | 0.0174563696971638 | 0.38220873 |
| NSC 736493 | Indenoisoquinoline derivative | 0.0187206825450445 | 0.20614585 |